Described are two cases in which desmopressin, administered to improve platelet function following cardiopulmonary bypass, was associated with hypotension. In light of our findings, it seems prudent to be cautious in administering desmopressin in the postbypass period. Further study of desmopressin is needed to define the nature and mechanism of these observed hemodynamic effects in the postbypass patient.
|Original language||English (US)|
|Number of pages||2|
|State||Published - Dec 1 1988|
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine